ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Circassia’s COPD drug gets FDA approval pharmatimes
April 02, 2019Circassia has announced the US Food and Drug Administration (FDA) approval of its chronic obstructive pulmonary disease (COPD) maintenance treatment, Duaklir. -
Circassia prepares for potential US launch of nitric oxide product pharmaphorum
February 19, 2019UK biotech Circassia has said that its partner AIT Therapeutics has held a meeting with the FDA that paves the way for premarket approval of its nitric oxide product for newborn babies with respiratory failure, AirNOvent. -
4 years after mega IPO, Circassia set for small-cap exchange
fiercebiotech
December 27, 2018Four years ago, Circassia looked to have ushered in a new era for biotech IPOs on the London Stock Exchange when it raised ￡200 million ($252 million) to..... -
Circassia takes on full US rights to AZ’ Tudorza
pharmatimes
December 13, 2018The firm already promotes the COPD therapy in the US under a profit share arrangement covering the drug and fellow COPD therapy Duaklir (aclidinium/formoterol), established by the two companies in April last year.
Pharma Sources Insight January 2025
